[go: up one dir, main page]

EA200600932A1 - Таблетки циталопрама гидробромида - Google Patents

Таблетки циталопрама гидробромида

Info

Publication number
EA200600932A1
EA200600932A1 EA200600932A EA200600932A EA200600932A1 EA 200600932 A1 EA200600932 A1 EA 200600932A1 EA 200600932 A EA200600932 A EA 200600932A EA 200600932 A EA200600932 A EA 200600932A EA 200600932 A1 EA200600932 A1 EA 200600932A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tablets
gydrobromide
citaloprama
microns
manufacture
Prior art date
Application number
EA200600932A
Other languages
English (en)
Other versions
EA010290B1 (ru
Inventor
Паль Фекете
Сильвия Феикуш
Жужа Славине Селл
Original Assignee
Эгиш Дьёдьсердьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эгиш Дьёдьсердьяр Рт. filed Critical Эгиш Дьёдьсердьяр Рт.
Publication of EA200600932A1 publication Critical patent/EA200600932A1/ru
Publication of EA010290B1 publication Critical patent/EA010290B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к таблеткам как с пленочным покрытием, так и без такового, содержащим в качестве активного ингредиента циталопрам гидробромид, имеющий средний размер частиц менее чем 40 мкм, в смеси с микрокристаллической целлюлозой, имеющей средний размер частиц в интервале 90-250 мкм, и другими эксципиентами, применимыми для изготовления таблеток. В изобретении также предложен способ их изготовления.
EA200600932A 2003-11-25 2004-11-24 Таблетки циталопрама гидробромида EA010290B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0303790A HU227491B1 (en) 2003-11-25 2003-11-25 Tablet containing citalopram hydrogen bromide
PCT/HU2004/000110 WO2005051374A1 (en) 2003-11-25 2004-11-24 Tablets of citalopram hydrobromide

Publications (2)

Publication Number Publication Date
EA200600932A1 true EA200600932A1 (ru) 2006-10-27
EA010290B1 EA010290B1 (ru) 2008-08-29

Family

ID=89981808

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600932A EA010290B1 (ru) 2003-11-25 2004-11-24 Таблетки циталопрама гидробромида

Country Status (9)

Country Link
EP (1) EP1694321A1 (ru)
BG (1) BG109587A (ru)
CZ (1) CZ2006376A3 (ru)
EA (1) EA010290B1 (ru)
HU (1) HU227491B1 (ru)
PL (1) PL379864A1 (ru)
SK (1) SK50532006A3 (ru)
UA (1) UA83094C2 (ru)
WO (1) WO2005051374A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI358407B (en) * 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607751B1 (en) * 1997-10-10 2003-08-19 Intellipharamaceutics Corp. Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.

Also Published As

Publication number Publication date
HU227491B1 (en) 2011-07-28
WO2005051374A1 (en) 2005-06-09
SK50532006A3 (sk) 2006-09-07
HU0303790D0 (en) 2004-03-01
HUP0303790A2 (hu) 2005-08-29
UA83094C2 (en) 2008-06-10
CZ2006376A3 (cs) 2006-10-11
EP1694321A1 (en) 2006-08-30
EA010290B1 (ru) 2008-08-29
PL379864A1 (pl) 2006-11-27
BG109587A (bg) 2006-12-29
HUP0303790A3 (en) 2005-09-28

Similar Documents

Publication Publication Date Title
ATE232087T1 (de) Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
EP1283054A4 (en) MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF
EA200401583A1 (ru) Таблетка лазофоксифена и ее покрытие
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
EA200301040A1 (ru) Способ производства фармацевтической композиции низкой дозы
EA200000487A1 (ru) Композиция пролонгированного высвобождения
AU2003285143A1 (en) Analysis of pharmaceutical solubility and stability
ATE329581T1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст
EA201001108A1 (ru) Диспергируемые во рту таблетки, содержащие основание эсциталопрама, и способ их получения
CA2490335A1 (en) Pharmaceutical composition as solid dosage form and method for manufacturing thereof
TW200501943A (en) Escitalopram hydrobromide and a method for the preparation thereof
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
EE200300279A (et) Toimeaine parendatud vabanemisprofiiliga mikroosakesed ja nende valmistamise meetod
EA200600932A1 (ru) Таблетки циталопрама гидробромида
SE0000303D0 (sv) Novel compounds
ATE333877T1 (de) Amlopidinbezylat-tabletten mit verbesserter stabilität
UA97355C2 (ru) Фармацевтическая композиция, включающая монтелукаст
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
SE0302924D0 (sv) Pharmaceutical composition having a cationic excipient
WO2004075825A3 (en) Dosage forms of amlodipine and processes for their preparation
DK1537132T3 (da) Salt af mortin-6-glucuronid
JP2005501049A (ja) 相乗効果のある賦形剤組成物
EA200300768A1 (ru) Фармацевтическая композиция, содержащая циталопрам
CA2473718A1 (en) Immediate-release pharmaceutical dosage form comprising polymorphous tibolone

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU